BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28138871)

  • 1. Clinical Relevance of Steroid Use in Neuro-Oncology.
    Ly KI; Wen PY
    Curr Neurol Neurosci Rep; 2017 Jan; 17(1):5. PubMed ID: 28138871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of corticosteroids in neuro-oncology.
    Koehler PJ
    Anticancer Drugs; 1995 Feb; 6(1):19-33. PubMed ID: 7756680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Management of Corticosteroids in Patients with Intracranial Malignancies.
    Dixit KS; Kumthekar PU
    Curr Treat Options Oncol; 2020 Jul; 21(9):77. PubMed ID: 32734428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids in brain cancer patients: benefits and pitfalls.
    Dietrich J; Rao K; Pastorino S; Kesari S
    Expert Rev Clin Pharmacol; 2011 Mar; 4(2):233-42. PubMed ID: 21666852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroids in the management of central nervous system tumours. Kids Neuro-Oncology Workshop (KNOWS).
    Glaser AW; Buxton N; Walker D
    Arch Dis Child; 1997 Jan; 76(1):76-8. PubMed ID: 9059170
    [No Abstract]   [Full Text] [Related]  

  • 6. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Steroids in the Treatment of Adults With Metastatic Brain Tumors.
    Ryken TC; Kuo JS; Prabhu RS; Sherman JH; Kalkanis SN; Olson JJ
    Neurosurgery; 2019 Mar; 84(3):E189-E191. PubMed ID: 30629207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group.
    Arvold ND; Armstrong TS; Warren KE; Chang SM; DeAngelis LM; Blakeley J; Chamberlain MC; Dunbar E; Loong HH; Macdonald DR; Reardon DA; Vogelbaum MA; Yuan Y; Weller M; van den Bent M; Wen PY
    Neuro Oncol; 2018 Jun; 20(7):897-906. PubMed ID: 29788429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of brain tumors and their treatment.
    Lacy J; Saadati H; Yu JB
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):779-96. PubMed ID: 22794283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cerebral lymphoma with a 5-year remission to single-agent corticosteroids.
    Kürtüncü M; Tüzün E; Durmuş H; Mutlu M; Akman-Demir G; Eraksoy M
    Leuk Lymphoma; 2009 Sep; 50(9):1552-3. PubMed ID: 19637089
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroradiologic Pearls for Neuro-oncology.
    Klein JP; Dietrich J
    Continuum (Minneap Minn); 2017 Dec; 23(6, Neuro-oncology):1619-1634. PubMed ID: 29200114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin Rechallenge After Hypersensitivity Reactions in Pediatric Patients With Low-Grade Glioma.
    Shah AC; Minturn JE; Li Y; Belasco JB; Phillips PC; Kang TI; Cole KA; Waanders AJ; Pollack R; Didomenico C; Wildes C; Fisher MJ
    Pediatr Blood Cancer; 2016 Jan; 63(1):21-6. PubMed ID: 26235452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal insufficiency and response to corticosteroids in hypotensive critically ill children with cancer.
    Hebbar KB; Petrillo T; Fortenberry JD
    J Crit Care; 2012 Oct; 27(5):480-7. PubMed ID: 22699033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Corticosteroids on Diagnostic Accuracy of Biopsy for Primary Central Nervous System Lymphoma.
    Binnahil M; Au K; Lu JQ; Wheatley BM; Sankar T
    Can J Neurol Sci; 2016 Sep; 43(5):721-5. PubMed ID: 27468790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of steroids in neuro-oncology].
    Barbero-Bordallo N; Gomez-Vicente L
    Rev Neurol; 2019 May; 68(9):389-397. PubMed ID: 31017292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genesis of the use of corticosteroids in the treatment and prevention of brain edema.
    McClelland S; Long DM
    Neurosurgery; 2008 Apr; 62(4):965-7; discussion 967-8. PubMed ID: 18496203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic profile, clinicopathological spectrum, and treatment outcomes of primary central nervous system tumors: Retrospective audit from an academic neuro-oncology unit.
    Gupta T; Epari S; Moiyadi A; Shetty P; Goda JS; Krishnatry R; Chinnaswamy G; Vora T; Menon H; Patil V; Sahay A; Bano N; Jalali R
    Indian J Cancer; 2017; 54(4):594-600. PubMed ID: 30082541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors.
    Tosi U; Marnell CS; Chang R; Cho WC; Ting R; Maachani UB; Souweidane MM
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid therapy in patients with brain tumors.
    Gutin PH
    Natl Cancer Inst Monogr; 1977 Dec; 46():151-6. PubMed ID: 349394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report.
    Leary SES; Park JR; Reid JM; Ralya AT; Baruchel S; Wu B; Roberts TPL; Liu X; Minard CG; Fox E; Weigel B; Blaney S
    Clin Cancer Res; 2017 Oct; 23(20):6062-6069. PubMed ID: 28751444
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and tolerability of treatments for allergic rhinitis in children.
    Baena-Cagnani CE
    Drug Saf; 2004; 27(12):883-98. PubMed ID: 15366976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.